251 related articles for article (PubMed ID: 17004969)
1. Modulation of ABH histo-blood group antigen expression in normal and myasthenic human thymus.
Sarafian VS; Marinova TT
APMIS; 2006 Oct; 114(10):669-74. PubMed ID: 17004969
[TBL] [Abstract][Full Text] [Related]
2. Thymic epithelial cells of human patients affected by myasthenia gravis overexpress IGF-I immunoreactivity.
Marinova TT; Kuerten S; Petrov DB; Angelov DN
APMIS; 2008 Jan; 116(1):50-8. PubMed ID: 18254780
[TBL] [Abstract][Full Text] [Related]
3. Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis and thymic epithelial tumors.
Marx A; Schömig D; Schultz A; Gattenlöhner S; Jung A; Kirchner T; Melms A; Müller-Hermelink HK
Thymus; 1994; 23(2):83-93. PubMed ID: 7725387
[TBL] [Abstract][Full Text] [Related]
4. Myoid cells and neuroendocrine markers in myasthenic thymuses.
Zółtowska A; Pawełczyk T; Stopa M; Skokowski J; Stepiński J; Roszkiewicz A; Nyka W
Arch Immunol Ther Exp (Warsz); 1998; 46(4):253-7. PubMed ID: 9779292
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Bcl-2 protein in the myasthenic thymus.
Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
[TBL] [Abstract][Full Text] [Related]
6. ABH histo-blood group antigens in human thymus involution.
Sarafian VS; Marinova TT
Arch Med Res; 2006 Oct; 37(7):844-7. PubMed ID: 16971223
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus.
Cimpean AM; Raica M; Encica S; Cornea R; Bocan V
Ann Anat; 2008; 190(3):238-45. PubMed ID: 18356031
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical comparative investigations of lymphatic tissue in reactive processes, myasthenic thymuses and Hodgkin's disease.
Zółtowska A
Arch Immunol Ther Exp (Warsz); 1995; 43(1):15-22. PubMed ID: 8744679
[TBL] [Abstract][Full Text] [Related]
9. Fas and nicotinic acetylcholine receptor in human myasthenic thymus--immunohistochemical study.
Kawanami S; Mori S; Kikuchi M; Shirakusa T
Fukuoka Igaku Zasshi; 1999 Jun; 90(6):286-94. PubMed ID: 10423925
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients.
Marie J; Wakkach A; Coudray A; Chastre E; Berrih-Aknin S; Gespach C
J Immunol; 1999 Feb; 162(4):2103-12. PubMed ID: 9973484
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
[TBL] [Abstract][Full Text] [Related]
12. Thymic epithelial antigen, acquired during ontogeny and defined by the anti-p19 monoclonal antibody, is lost in thymomas.
Savino W; Berrih S; Dardenne M
Lab Invest; 1984 Sep; 51(3):292-6. PubMed ID: 6433106
[TBL] [Abstract][Full Text] [Related]
13. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.
Chang KC; Wu MH; Jones D; Chen FF; Tseng YL
J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical localization of thymosin-alpha 1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures.
Dalakas MC; Engel WK; McClure JE; Goldstein AL; Askanas V
J Neurol Sci; 1981 May; 50(2):239-47. PubMed ID: 7014787
[TBL] [Abstract][Full Text] [Related]
15. Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.
Marx A; Wilisch A; Schultz A; Greiner A; Magi B; Pallini V; Schalke B; Toyka K; Nix W; Kirchner T; Müller-Hermelink HK
Am J Pathol; 1996 Jun; 148(6):1839-50. PubMed ID: 8669470
[TBL] [Abstract][Full Text] [Related]
16. Thymic epithelial cells expressed unusual follicular dendritic cell markers: thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Masunaga A; Iwamoto S; Nakamura H; Usuda R; Masuda M; Suzuki S; Miyazaki A; Suzuki T; Mitsuya T; Yoshitake T
Pathol Int; 2008 Jun; 58(6):402-5. PubMed ID: 18477221
[TBL] [Abstract][Full Text] [Related]
17. In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis.
Aime C; Cohen-Kaminsky S; Berrih-Aknin S
J Clin Immunol; 1991 Sep; 11(5):268-78. PubMed ID: 1795043
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between expression of Cat V and clinicopathologic character of myasthenia gravis in patients with thymoma].
Wang Y; Huang Y; Luo DY; Yuan O; Gong RR; Qiu GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):886-8. PubMed ID: 17236586
[TBL] [Abstract][Full Text] [Related]
19. Thymic myoid cells--stimulants and/or targets of autoimmune myasthenia gravis.
Müller-Hermelink HK; Kirchner T; Hoppe F; Demel S
Monogr Allergy; 1988; 25():68-74. PubMed ID: 2459614
[No Abstract] [Full Text] [Related]
20. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
